Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
life sciences
national blog main
national top stories
roche
alexion pharmaceuticals
alnylam pharmaceuticals
billy dunn
biogen
boehringer ingelheim
boston
boston blog main
boston top stories
deals
dicerna pharamceuticals
drug prices
drug pricing
europe top stories
evrysdi
gene therapy
genentech
hepatitis b
hepatitis b virus
hereditary transthyretin amyloidosis
ionis pharmaceuticals
national
new york top stories
novartis
nusinersen
patisiran
risdiplam
rna drugs
rna interference
san francisco top stories
spinal muscular atrophy
spinraza
world health organization
zolgensma
What
drug
intended
2
×
roche
2
×
approved
atrophy
caught
causing
daily
dicerna
disease
evrysdi
eye
fda
friday
gene
green
hepatitis
home
lights
liquid
medicine
medicines
muscular
new
oral
patients
pay
pharma
pharmaceuticals
producing
protein
research
risdiplam
spinal
stop
team
therapy
Language
unset
2
×
Current search:
intended
×
roche
×
unset
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug